Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Compliance troubles emerge at Pfizer, Teva, Wockhardt and Xiamen Origin
It has been an
unprecedented week where compliance glitches have emerged from almost all parts
of t
Will data integrity concerns on clinical trials done at GVK Biosciences go beyond Europe?
Over
700 commonly used generic medicines were
recommended for suspension by the European Medic